Astrana Health (ASTH) Shares Outstanding (Weighted Average) (2010 - 2026)

Astrana Health has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $48.9 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $48.9 million, up 0.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $48.9 million (up 0.79% YoY), and the FY2025 annual result was $49.1 million, up 3.11% from the prior year.
• Shares Outstanding (Weighted Average) came in at $48.9 million for Q1 2026 at Astrana Health, roughly flat from $49.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $49.1 million in Q4 2025 to a low of $44.7 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $47.3 million (2024), against an average of $47.0 million.
• Across the five-year window, Shares Outstanding (Weighted Average) gained 5.54% in 2022 and climbed 0.79% in 2026, its largest moves.
• Astrana Health's Shares Outstanding (Weighted Average) stood at $45.0 million in 2022, then increased by 3.52% to $46.6 million in 2023, then increased by 2.24% to $47.6 million in 2024, then gained by 3.11% to $49.1 million in 2025, then dropped by 0.45% to $48.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $48.9 million (Q1 2026), $49.1 million (Q4 2025), and $49.0 million (Q3 2025), per Business Quant data.